Skip to main content

Takeda Pharmaceutical shareholders approve $62 billion bid for Shire

Takeda Pharmaceutical Co. won approval from shareholders Wednesday for its $62 billion bid for the U.K.’s Shire PLC, clearing the path for the biggest-ever overseas acquisition by a Japanese company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.